Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds.
Tipton
K F
KF
Department of Biochemistry, Trinity College, Dublin, Ireland.
Singer
T P
TP
D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine / Q000378:metabolism / Q000494:pharmacology*; D015655:1-Methyl-4-phenylpyridinium / Q000493:pharmacokinetics / Q000494:pharmacology*; D000375:Aging / Q000502:physiology; D000818:Animals; D001692:Biological Transport; D006801:Humans; D008928:Mitochondria / Q000187:drug effects / Q000502:physiology; D009420:Nervous System / Q000187:drug effects*; D010084:Oxidation-Reduction; D010300:Parkinson Disease / Q000503:physiopathology; D012642:Selegiline / Q000494:pharmacology; D013045:Species Specificity
D012642:Selegiline; D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; D015655:1-Methyl-4-phenylpyridinium